Discover 175 paid clinical trials in Burlington, Vermont. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 175
Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial
for
Palliative Radiotherapy,
Location: Burlington VT
Sponsor: University of Vermont Medical Center
Sex: All
Age: 18+
Code: NCT06778408
Phase2, Recruiting
DOAC - Dosing Options in AntiCoagulation Prophylaxis
for
Cancer, VTE (Venous Thromboembolism)
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 18+
Code: NCT07005024
Phase3, Recruiting
Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor
for
Atrial Fibrillation, Diastolic Dysfunction,
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 18+
Code: NCT05745337
Phase1, Recruiting
Addition of Clonidine to Ropivacaine in Adductor Canal Block
for
Postoperative Pain
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 18+
Code: NCT03057015
Recruiting
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
for
Parkinson Disease, Constipation
Location: Burlington VT
Sponsor: University of Vermont Medical Center
Sex: All
Age: 18+
Code: NCT05603715
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Multi-disciplinary Care for Brain Metastases
for
Brain Metastases, Adult
Location: Burlington VT
Sponsor: University of Vermont Medical Center
Sex: All
Age: 18+
Code: NCT06280300
Recruiting
Remote Smoking Cessation in Hospitalized Cardiac Patients
for
Smoking Cessation
Location: Burlington VT
Sponsor: University of Vermont Medical Center
Sex: All
Age: 18+
Code: NCT05738408
Recruiting
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
for
Venous Thromboembolism
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 18+
Code: NCT05240508
Recruiting
Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure